logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Complicated Urinary Tract Infection

    FiltersReset Filters
    10 results

    • amikacin sulfate

      (Amikacin Sulfate)
      Mullan Pharmaceutical Inc.
      Usage: Amikacin Sulfate Injection is indicated for the short-term treatment of serious infections caused by susceptible Gram-negative bacteria, including Pseudomonas and Escherichia coli, among others. It is effective in conditions such as septicemia, respiratory tract infections, and complicated urinary tract infections, and may also treat staphylococcal infections under specific circumstances.

    • ciprofloxacin

      (ciprofloxacin)
      Chartwell RX, LLC
      Usage: Ciprofloxacin is indicated for treating various infections in adults, including skin, bone, joint, intra-abdominal infections, infectious diarrhea, typhoid fever, gonorrhea, inhalational anthrax, plague, chronic bacterial prostatitis, lower respiratory tract infections, urinary tract infections, acute sinusitis, and pediatric complicated urinary tract infections.

    • ciprofloxacin

      (Ciprofloxacin Tablets)
      Yiling Pharmaceutical, Inc.
      Usage: Ciprofloxacin tablets are indicated for treating various infections in adults, including skin and skin structure infections, bone and joint infections, complicated intra-abdominal infections, infectious diarrhea, typhoid fever, uncomplicated gonorrhea, inhalational anthrax (post-exposure), plague, chronic bacterial prostatitis, lower respiratory tract infections, and urinary tract infections.

    • ciprofloxacin in dextrose

      (ciprofloxacin)
      Hospira, Inc.
      Usage: Ciprofloxacin Injection is indicated for treating various infections in adults, including skin, bone and joint, complicated intra-abdominal, nosocomial pneumonia, febrile neutropenia, inhalational anthrax (post-exposure), plague, chronic bacterial prostatitis, lower respiratory tract infections, complicated urinary tract infections, and acute sinusitis.

    • ertapenem sodium

      (Ertapenem)
      NorthStar RxLLC
      Usage: Ertapenem for injection is indicated for treating complicated intra-abdominal infections, skin and skin structure infections (including diabetic foot infections without osteomyelitis), community-acquired pneumonia, complicated urinary tract infections, acute pelvic infections, and for prophylaxis of surgical site infection following elective colorectal surgery.

    • fetroja

      (Cefiderocol sulfate tosylate)
      Shionogi Inc.
      Usage: FETROJA® is indicated for patients aged 18 and older for treating complicated urinary tract infections (cUTIs) including pyelonephritis, and hospital-acquired/ventilator-associated bacterial pneumonia, caused by susceptible Gram-negative bacteria like E. coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Use should limit drug resistance.

    • levofloxacin

      (Levofloxacin)
      Hospira, Inc
      Usage: Levofloxacin Injection is indicated for treating mild to severe infections in adults, including nosocomial and community-acquired pneumonia, skin infections, chronic bacterial prostatitis, inhalational anthrax, plague, and complicated urinary tract infections. It is used when intravenous administration is preferred due to patient conditions.

    • recarbrio

      (imipenem anhydrous, cilastatin, and relebactam anhydrous)
      Merck Sharp & Dohme LLC
      Usage: RECARBRIO is indicated for treating adults with hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, complicated urinary tract infections, and complicated intra-abdominal infections caused by specific susceptible gram-negative bacteria, particularly when limited treatment options exist. Its use aims to combat drug-resistant bacterial development.

    • vabomere

      (Meropenem-Vaborbactam)
      Melinta Therapeutics, LLC
      Usage: VABOMERE® is indicated for treating complicated urinary tract infections (cUTI), including pyelonephritis, in patients 18 and older, caused by susceptible bacteria such as E. coli, Klebsiella pneumoniae, and Enterobacter cloacae species complex. It aims to reduce drug-resistant bacteria development.

    • zerbaxa

      (ceftolozane and tazobactam)
      Merck Sharp & Dohme LLC
      Usage: ZERBAXA is indicated for the treatment of complicated intra-abdominal infections, complicated urinary tract infections (including pyelonephritis), and hospital-acquired or ventilator-associated bacterial pneumonia in adults and pediatric patients, targeting specific susceptible Gram-negative and Gram-positive bacteria. Usage should be guided by culture results and epidemiology.